IIM
ADMA icon

INTECH Investment Management’s ADMA Biologics ADMA Stock Holding History

INTECH Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
150,580
-5,868
-4% -$53.5K 0.01% 925
2026
Q1 		$1.41M Buy
156,448
+34,857
+29% +$550K 0.01% 851
2025
Q4 		$2.22M Sell
121,591
-2,423
-2% -$40.8K 0.02% 688
2025
Q3 		$1.82M Sell
124,014
-11,486
-8% -$197K 0.02% 830
2025
Q2 		$2.47M Sell
135,500
-157,095
-54% -$3.2M 0.02% 640
2025
Q1 		$5.81M Buy
292,595
+181,839
+164% +$3.14M 0.06% 282
2024
Q4 		$1.9M Buy
110,756
+48,636
+78% +$915K 0.02% 740
2024
Q3 		$1.24M Buy
+62,120
New +$966K 0.01% 687

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

INTECH Investment Management's ADMA Position: Q2 2026 in Review

INTECH Investment Management reduced its ADMA Biologics (ADMA) stake by 3.8% in Q2 2026, selling an estimated $53.5K and leaving 150,580 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #925.

INTECH Investment Management first reported a position in ADMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.81M in Q1 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • INTECH Investment Management held 150,580 shares of ADMA Biologics worth $1.26M as of Q2 2026.
  • INTECH Investment Management sold 5,868 ADMA Biologics shares in Q2 2026, an estimated $53.5K.
  • ADMA Biologics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #925 holding.
  • INTECH Investment Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's ADMA Biologics position peaked at $5.81M in Q1 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.